A Questionnaire Study on the Knowledge, Attitude, and Practice of Pharmacovigilance among the Medical Post Graduates in a Teaching Hospital in West Uttar Pradesh
Background: Pharmacovigilance aids in early detection of ADRs and as well as identification of various risk factors. Reporting of ADRs is crucial for the success of pharmacovigilance program. Aims/Objective: This questionnaire based study among medical resident’s aims at assessing knowledge, attitude & practice towards adverse drug reaction reporting in the teaching hospital attached to a private medical college and design methods to improve existing ADR reporting system in our setup. Methods: This study is a questionnaire based cross-sectional study. It was conducted at Teerthanker Mahaveer Medical College & research Centre, Moradabad, West Uttar Pradesh, among the first year and final year medical post graduates/PGs, by using a pre-validated, modified questionnaire on knowledge, attitude & practice. A total of 90 questionnaires were duly filled out by the post graduates. Data was analyzed by using SPSS V.20. The chi-square test was used to determine statistical significance. Results: Majority (89%) reported to have reasonable knowledge of adverse drug reactions, but reported an average degree of knowledge regarding various aspects of pharmacovigilance. 61% respondents were not aware of presence of an AMC affiliated to this hospital. Final year medical post graduates were found to have poor attitude towards acts of reporting of adverse drug reactions although they pose better knowledge regarding drug safety as well as importance of ADR reporting. Lack of training (90%) on ADR reporting was also recorded. Conclusions: This study recorded average knowledge, positive attitude towards necessity of reporting of ADRs of medical post graduates. Necessity of educational interventions to update knowledge and improve practice of ADR reporting were identified as important measures that need to be taken care of.
2. Importance of ADR reporting in India. [Last accessed on 2014 Sep 15]. Available from:http://www.pharmacovigilance.co.in.
3. Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016 Sep-Oct; 81:323-34. doi: 10.1016/j.vascn.2016.04.011. Epub 2016 Apr 20.
4. Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Begaud B. Incidence of serious adverse drug reactions in general practice: A prospective study. Clin Pharmacol Ther. 2001; 69:458-62.
5. Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc. Patient Saf. 2012; 4:75-80.
6. Posthumus A.A., Alingh C.C., Zwaan C.C. Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study. BMJ Open. 2012.
7. World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions. Geneva: WHO/EDM/QSM/2002.2; 2002.
8. Protocol of National Pharmacovigilance Programme, November 2004. CDSCO, Ministry of Health and Family Welfare, Government of India. November, 2004. Available: http://www.cdsco.nic.in/html/Pharmacovigilance%20protocol%20.pdf.
9. Tandon VR, Mahajan V, Khajuria V, Gullani Z. Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India. Indian J Pharmacol 2015; 47(1):65-71.
10. Upadhyaya HB, Vora MB, Nagar JG, Patel PB. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. Journal of advanced pharmaceutical technology & research. 2015; 6(1):29.
11. Mittal N, Gupta M, Singla M. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India. Cutan Ocul Toxicol. 2014 Dec; 33(4):289-93. doi: 10.3109/15569527.2013.857678. Epub 2014 Feb 11.
12. Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis. PLoS ONE .2016; 11(3): e0152221. doi:10.1371/journal.pone.0152221.
13. Datta S, Sengupta S. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting in a tertiary care teaching hospital of Sikkim. Perspect Clin Res 2015; 6:200-6.
14. Pimpalkhute SA, Jaiswal KM, Sontakke SD, Bajait CS, Gaikwad A. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital. Indian J Med Sci 2012; 66:55‑61.
15. Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions - A way of dealing with an old problem? Eur J Clin Pharmacol 2006; 62:381‑5.
16. Reddy P, Varma SK, Reddy S. Knowledge, attitude and practice of ADR reporting among clinical participants: A rural medical college survey. J Drug Discov Ther 2014; 2:8‑13.
17. Lateef M Khan, Sameer E Al-Harthi, Abdel Moneim M Osman, Mai A Alim A Sattar and Ahmed S Alia. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016 Jul; 24(4): 485-493. PMCID: PMC4908100.
18. Elena Lopez-Gonzalez, Maria T. Herdeiro, María Piñeiro-Lamas, Adolfo Figueiras. Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial. Drug Safety. 2015; 38(2):189.
19. Hanafi S, Torkamandi H, Hayatshahi A, Gholami K, Shahmirzadi NA, Javadi MR. An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions. Iranian Journal of Nursing and Midwifery Research. 2014; 19(1):101-106.
Copyright (c) 2017 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.